Dechu P Puliyanda

Title(s)HS Clinical Professor, Pediatrics
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients. Clin Transplant. 2022 Aug; 36(8):e14734. Pearl M, Weng PL, Chen L, Dokras A, Pizzo H, Garrison J, Butler C, Zhang J, Reed EF, Kim IK, Choi J, Haas M, Zhang X, Vo A, Chambers ET, Ettenger R, Jordan S, Puliyanda D. PMID: 35657013.
      View in: PubMed   Mentions:    Fields:    
    2. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection. Pediatr Transplant. 2022 06; 26(4):e14258. Steggerda JA, Pizzo H, Garrison J, Zhang X, Haas M, Kim IK, Jordan SC, Puliyanda DP. PMID: 35340104.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Use of Rituximab for persistent EBV DNAemia, and Its effect on donor-specific antibody development in pediatric renal transplant recipients: A case series. Pediatr Transplant. 2021 12; 25(8):e14113. Puliyanda DP, Jordan SC, Kim IK, Patel M, Murthy A, Huang E, Zhang X, Reinsmoen N, Kamil ES, Toyoda M. PMID: 34418254.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Development of CMV-specific cytotoxic T cells (CMV-Tc) in pediatric renal transplant recipients with CMV viremia. Pediatr Transplant. 2021 12; 25(8):e14119. Pizzo H, Shin B, Garrison J, Huang E, Malekzadeh M, Jordan SC, Puliyanda D, Toyoda M. PMID: 34390094.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    5. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants. Pediatr Transplant. 2021 03; 25(2):e13850. Puliyanda DP, Swinford R, Pizzo H, Garrison J, De Golovine AM, Jordan SC. PMID: 33217125.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. Early outcomes comparing induction with antithymocyte globulin vs alemtuzumab in two steroid-avoidance protocols in pediatric renal transplantation. Pediatr Transplant. 2020 05; 24(3):e13685. Puliyanda DP, Pizzo H, Rodig N, Somers MJG. PMID: 32112514.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    7. Letter to Editor: HIV medicine. HIV Med. 2019 08; 20(7):e15. Buck WC, Puliyanda D, Nielsen-Saines K. PMID: 31034130.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Collagen type III glomerulopathy. Kidney Int. 2018 Jun; 93(6):1490. Pizzo HP, Haas M, Puliyanda D. PMID: 29792275.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients. Am J Transplant. 2018 12; 18(12):2955-2964. Jordan SC, Choi J, Aubert O, Haas M, Loupy A, Huang E, Peng A, Kim I, Louie S, Ammerman N, Najjar R, Puliyanda D, Vo A. PMID: 29637714.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    10. Clinical and histopathologic features of antibody-mediated rejection among pediatric renal transplant recipients with preformed vs de novo donor-specific antibodies. Pediatr Transplant. 2017 Dec; 21(8). Steggerda JA, Kim IK, Haas M, Zhang X, Kang A, Pizzo H, Kamil E, Jordan S, Puliyanda D. PMID: 29159992.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipients. Pediatr Transplant. 2017 Dec; 21(8). Kim IK, Choi J, Vo A, Kang A, Steggerda J, Louie S, Haas M, Mirocha J, Cohen JL, Pizzo H, Kamil ES, Jordan SC, Puliyanda D. PMID: 28929636.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients. Transplantation. 2017 04; 101(4):883-889. Kim IK, Choi J, Vo AA, Kang A, Patel M, Toyoda M, Mirocha J, Kamil ES, Cohen JL, Louie S, Galera O, Jordan SC, Puliyanda DP. PMID: 27495773; PMCID: PMC7228615.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    13. Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients. Am J Transplant. 2017 Sep; 17(9):2381-2389. Choi J, Aubert O, Vo A, Loupy A, Haas M, Puliyanda D, Kim I, Louie S, Kang A, Peng A, Kahwaji J, Reinsmoen N, Toyoda M, Jordan SC. PMID: 28199785.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    14. Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection. Pediatr Nephrol. 2016 08; 31(8):1341-8. Pearl MH, Nayak AB, Ettenger RB, Puliyanda D, Palma Diaz MF, Zhang Q, Reed EF, Tsai EW. PMID: 27048228; PMCID: PMC5590841.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    15. A Phase I/II Trial of the Interleukin-6 Receptor-Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients. Transplantation. 2015 Nov; 99(11):2356-63. Vo AA, Choi J, Kim I, Louie S, Cisneros K, Kahwaji J, Toyoda M, Ge S, Haas M, Puliyanda D, Reinsmoen N, Peng A, Villicana R, Jordan SC. PMID: 26018350.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    16. A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients. Transplantation. 2015 Feb; 99(2):299-308. Vo AA, Zeevi A, Choi J, Cisneros K, Toyoda M, Kahwaji J, Peng A, Villicana R, Puliyanda D, Reinsmoen N, Haas M, Jordan SC. PMID: 25606785.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    17. The effects of everolimus on tuberous sclerosis-associated lesions can be dramatic but may be impermanent. Pediatr Nephrol. 2015 Jan; 30(1):173-7. Miller JM, Wachsman A, Haker K, Majlessipour F, Danielpour M, Puliyanda D. PMID: 25194630.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. The authors' reply. Transplantation. 2014 Jul 27; 98(2):e8-9. Kahwaji J, Jordan S, Puliyanda D, Toyoda M. PMID: 25022239.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    19. Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximab. Transplantation. 2014 Apr 15; 97(7):755-61. Barbosa D, Kahwaji J, Puliyanda D, Mirocha J, Reinsmoen N, Lai CH, Villicana R, Peng A, Jordan SC, Vo A, Toyoda M. PMID: 24686425.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    20. Good outcome of kidney transplants in recipients of young donors: a NAPRTCS data analysis. Pediatr Transplant. 2011 Mar; 15(2):167-71. Moudgil A, Martz K, Stablein DM, Puliyanda DP. PMID: 21199208.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    21. Variables affecting estimated glomerular filtration rate after renal transplantation in children: a NAPRTCS data analysis. Pediatr Transplant. 2010 Mar; 14(2):288-94. Moudgil A, Martz K, Stablein DM, Puliyanda DP. PMID: 19686443.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients. Pediatr Transplant. 2008 Nov; 12(7):778-84. Toyoda M, Moudgil A, Warady BA, Puliyanda DP, Jordan SC. PMID: 18331541.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    23. Outcome of management strategies for BK virus replication in pediatric renal transplant recipients. Pediatr Transplant. 2008 Mar; 12(2):180-6. Puliyanda DP, Toyoda M, Traum AZ, Flores FX, Jordan S, Moudgil A, Somers MJ. PMID: 18307666.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    24. The onset of rapidly progressive neurologic deterioration after a brief gastrointestinal illness in a renal allograft recipient. Transpl Infect Dis. 2007 Jun; 9(2):142-7. Hristea I, Bunnapradist S, Peng A, Puliyanda D, Vo A, Jordan SC. PMID: 17462001.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    25. Younger age and antibody induction increase the risk for infection in pediatric renal transplantation: a NAPRTCS report. Am J Transplant. 2007 Mar; 7(3):662-6. Puliyanda DP, Stablein DM, Dharnidharka VR. PMID: 17250558.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    26. Induction therapy in pediatric renal transplant recipients: an overview. Paediatr Drugs. 2007; 9(5):323-41. Moudgil A, Puliyanda D. PMID: 17927304.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    27. Preventing recurrence of focal segmental glomerulosclerosis following renal transplantation: a case report. Pediatr Transplant. 2006 Dec; 10(8):962-5. Couloures K, Pepkowitz SH, Goldfinger D, Kamil ES, Puliyanda DP. PMID: 17096767.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    28. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy. Clin Transplant. 2006 May-Jun; 20(3):289-94. Puliyanda DP, Amet N, Dhawan A, Hilo L, Radha RK, Bunnapradist S, Czer L, Martin P, Jordan S, Toyoda M. PMID: 16824143.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    29. Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience. Clin J Am Soc Nephrol. 2006 Jul; 1(4):844-52. Vo AA, Cam V, Toyoda M, Puliyanda DP, Lukovsky M, Bunnapradist S, Peng A, Yang K, Jordan SC. PMID: 17699296.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    30. Passive immunization against cytomegalovirus during pregnancy. N Engl J Med. 2005 Dec 29; 353(26):2818-20; author reply 2818-20. Silverman NS, Puliyanda D, Lehman D. PMID: 16382073.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients. Transplantation. 2005 Jul 27; 80(2):198-205. Toyoda M, Puliyanda DP, Amet N, Baden L, Cam V, Radha R, Pao A, Vo A, Bunnapradist S, Moudgil A, Jordan SC. PMID: 16041264.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    32. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient. Transpl Infect Dis. 2005 Jun; 7(2):71-4. Puliyanda DP, Silverman NS, Lehman D, Vo A, Bunnapradist S, Radha RK, Toyoda M, Jordan SC. PMID: 16150094.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    33. Cellular immune responses to cytomegalovirus in renal transplant recipients. Am J Transplant. 2005 Jan; 5(1):110-7. Radha R, Jordan S, Puliyanda D, Bunnapradist S, Petrosyan A, Amet N, Toyoda M. PMID: 15636618.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    34. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation. 2003 Aug 27; 76(4):631-6. Jordan SC, Vo A, Bunnapradist S, Toyoda M, Peng A, Puliyanda D, Kamil E, Tyan D. PMID: 12973100.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    35. Fabry disease in a renal allograft. Am J Transplant. 2003 Aug; 3(8):1030-2. Puliyanda DP, Wilcox WR, Bunnapradist S, Nast CC, Jordan SC. PMID: 12859541.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Calpain-mediated AQP2 proteolysis in inner medullary collecting duct. Biochem Biophys Res Commun. 2003 Mar 28; 303(1):52-8. Puliyanda DP, Ward DT, Baum MA, Hammond TG, Harris HW. PMID: 12646165.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    37. Posttransplantation lymphoproliferative disorder presenting as a unilateral leg mass 10 years after kidney transplantation. Transplantation. 2002 Dec 15; 74(11):1648-51. Bunnapradist S, Vo A, Toyoda M, Alsabeh R, Lockhart C, Puliyanda D, Jordan SC. PMID: 12490805.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Utility of hemodialysis in maple syrup urine disease. Pediatr Nephrol. 2002 Apr; 17(4):239-42. Puliyanda DP, Harmon WE, Peterschmitt MJ, Irons M, Somers MJ. PMID: 11956873.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    Dechu's Networks
    Concepts (190)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (7)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California